All this raises a question about the physiopathological involvement of Btg2 in human medulloblastoma tumorigenesis; indeed, we have previously observed that the expression of Btg2 varies considerably among different types of human MB tumors, with a prevalent decrease below the level measured in control cerebellum tissue (28). Here, BTG2 is linked to medulloblastoma.